Averages describe populations, not individuals, and a meaningful minority maintain or continue losing after stopping, particularly those who sustain substantial behavioral changes
Who should avoid these treatments
Practices should confirm their EHR supports D22.4 and validates against current fiscal year code tables
The long-term sympathoinhibition suppresses renin release, mimicking the effects of beta beta-blockers through -1 receptors in the renal iuxtaglomerular apparatus, leading to an increase of the ARR
However, we implemented the rigorous PS procedures (e.g., matching, weighting) to enhance between-group comparability and the sensitivity analyses to account for patients medication use behaviors (i.e., as-treated scenario, stable GLP-1RAs users) and possible healthy user bias to minimize potential confounding and bias commonly seen in retrospective studies